Torrent Pharmaceuticals Limited (TORNTPHARM) — Corporate Action Announcement

StockFin.ai Try Free →

📢 Key Event
Proposed final dividend of ₹9 per share (180% payout) on ₹5 face value, subject to shareholder approval at AGM

🔄 What Changed
Proposed ₹5,000 crore capital raise via QIP or other instruments

🔮 What's Next
Record date for dividend eligibility set for May 29, 2026

💡 Investor Takeaway
Shareholders must approve the dividend and capital raise at the AGM, with the dividend contingent on approval and record date confirmation

Torrent Pharmaceuticals proposed a final dividend of ₹9 per share (180% payout) on a ₹5 face value, subject to shareholder approval at the upcoming AGM, alongside approval of FY2026 audited results showing standalone revenue of ₹10,712 crores and consolidated revenue of ₹10,730 crores, with net profit of ₹2,192 crores. The filing also includes a recommendation for a ₹5,000 crore capital raise via QIP or other instruments, fixation of May 29, 2026 as the record date for dividend eligibility, and an unmodified auditor opinion confirming compliance with SEBI regulations and Indian Accounting Standards.

📄 View Original Announcement (PDF)

📊 Stock Analysis — TORNTPHARM ✨ Ask AI About This

About Torrent Pharmaceuticals Limited (TORNTPHARM)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹1,49,108.91 Cr P/E: 80.1

View full TORNTPHARM stock details →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Torrent Pharmaceuticals Limited (TORNTPHARM) — Corporate Action Announcement

About Torrent Pharmaceuticals Limited (TORNTPHARM)

Recent Announcements from Torrent Pharmaceuticals Limited